Arax Advisory Partners’s AnaptysBio ANAB Stock Holding History

Arax Advisory Partners’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.8K	Buy	+176	New	+$10.7K	﹤0.01%	4249
2026 Q1	–	Sell	-8	Closed	-$388	–	3795
2025 Q4	$388	Buy	+8	New	+$312	﹤0.01%	3644
2024 Q4	–	Sell	-61	Closed	-$2.04K	–	2442
2024 Q3	$2.04K	Hold	61	–	–	﹤0.01%	2057
2024 Q2	$1.53K	Buy	+61	New	+$1.42K	﹤0.01%	2049

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Arax Advisory Partners's ANAB Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in AnaptysBio (ANAB) in Q2 2026: 176 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #4249 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in ANAB as recently as Q4 2025.

Arax Advisory Partners first reported a position in ANAB in Q2 2024 and has held it in 4 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

Arax Advisory Partners held 176 shares of AnaptysBio worth $11.8K as of Q2 2026.
AnaptysBio was a new Arax Advisory Partners position in Q2 2026.
AnaptysBio made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4249 holding.
Arax Advisory Partners first reported a position in AnaptysBio in Q2 2024 and has held it in 4 quarters since.
213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.